Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity is a pseudogene related to the microtubule affinity regulating kinase 3 (MARK3) gene. Pseudogenes are segments of DNA that are similar to functional genes but contain mutations or deletions that prevent them from encoding functional proteins. As such, MARK3P3 does not produce an active protein product, has no known biological function or disease association, is not considered a therapeutic target, and has no described interactions with drugs. The absence of curated information and functional data means it cannot be regarded as a valid target for therapeutic development, nor does it have standardized molecular or functional classification. If you intended to refer to the functional kinase "Microtubule affinity regulating kinase 3" (MARK3), please clarify, as the pseudogene version has none of the properties relevant for target-based research or drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule affinity regulating kinase 3 pseudogene 3 (MARK3P3).